PERCEPTIVE ADVISORS LLC

13F Portfolio Filings

Most recent 13F
Q2 2026
13D/G filings
13D on 10 securities, 13G on 63 securities
Location
New York, NY
CIK
0001224962
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q2 2026 109 6,661,817 PRAX, SYRE, CELC, ASND 13F-HR 8/14/2026 000101297526000777
Q1 2026 94 5,117,574 PRAX, CELC, ASND, ROIV RESTATEMENT 5/29/2026 000101297526000499
Q4 2025 116 5,610,284 PRAX, CELC, RYTM, ASND 13F-HR 2/17/2026 000101297526000155
Q3 2025 93 3,463,098 RYTM, ASND, ACLX, CELC 13F-HR 11/14/2025 000101297525000762
Q2 2025 85 2,697,358 VRNA, ASND, ACLX, RYTM 13F-HR 8/14/2025 000101297525000446
Q1 2025 87 2,830,733 VRNA, ACLX, FOLD, EWTX RESTATEMENT 8/6/2025 000101297525000422
Q4 2024 99 3,628,669 VRNA, ACLX, FOLD, RYTM 13F-HR 2/14/2025 000101297525000090
Q3 2024 108 4,726,735 ACLX, NUVL, FOLD, IOVA 13F-HR 11/14/2024 000101297524000488
Q2 2024 110 4,151,786 CERE, FOLD, ACLX, IOVA RESTATEMENT 8/16/2024 000101297524000346
Q1 2024 112 5,715,499 CERE, FOLD, IOVA, ACLX RESTATEMENT 8/6/2024 000101297524000315
Q4 2023 101 4,479,991 CERE, FOLD, LIANY, ACLX RESTATEMENT 2/26/2024 000101297524000112
Q3 2023 97 2,997,910 FOLD, CERE, IMVT, ACLX 13F-HR 11/14/2023 000101297523000471
Q2 2023 95 3,454,832 FOLD, CERE, LIANY, ACLX RESTATEMENT 8/24/2023 000101297523000365
Q1 2023 99 3,387,005 FOLD, RETA, AMLX, CERE RESTATEMENT 5/16/2023 000101297523000242
Q4 2022 96 3,561,179 FOLD, AMLX, MDGL, CERE 13F-HR 2/14/2023 000101297523000099
Q3 2022 116 3,445,660 FOLD, MRTX, CERE, GBT 13F-HR 11/14/2022 000101297522000502
Q2 2022 111 3,192,812 TRAVERE THERAPEUTICS INC, FOLD, MRTX, CERE 13F-HR 8/15/2022 000101297522000365
Q1 2022 135 4,992,282 TRAVERE THERAPEUTICS INC, FOLD, SWTX, LIANY 13F-HR 5/16/2022 000101297522000241
Q4 2021 147 6,488,711 TRAVERE THERAPEUTICS INC, MRTX, LIANY, FOLD NEW HOLDINGS 5/4/2022 000101297522000209
Q4 2021 145 6,477,012 TRAVERE THERAPEUTICS INC, MRTX, LIANY, FOLD RESTATEMENT 4/13/2022 000101297522000160
Q3 2021 140 6,884,438 MRTX, TRAVERE THERAPEUTICS INC, BBIO, SWTX RESTATEMENT 12/3/2021 000101297521000492
Q2 2021 150 7,706,312 MRTX, BBIO, SWTX, RETROPHIN INC NEW HOLDINGS 8/17/2021 000101297521000326
Q2 2021 149 7,690,907 MRTX, BBIO, SWTX, RETROPHIN INC 13F-HR 8/16/2021 000101297521000320
Q1 2021 139 7,907,737 MRTX, BBIO, RETROPHIN INC, SWTX RESTATEMENT 8/13/2021 000101297521000299
Q1 2021 139 7,928,028 MRTX, BBIO, RETROPHIN INC, SWTX NEW HOLDINGS 6/10/2021 000101297521000242
Q4 2020 139 9,318,287 MRTX, FOLD, BBIO, RETROPHIN INC 13F-HR 2/16/2021 000101297521000086
Q3 2020 126 6,849,575 MRTX, RETROPHIN INC, FOLD, IOVA 13F-HR 11/16/2020 000101297520000835
Q2 2020 125 6,171,121 FOLD, GBT, RETROPHIN INC, IOVA RESTATEMENT 8/17/2020 000101297520000701
Q1 2020 113 3,839,552 IOVA, GBT, NBIX, MRTX RESTATEMENT 5/18/2020 000101297520000472
Q4 2019 114 5,034,133 GBT, MRTX, NBIX, KOD RESTATEMENT 2/19/2020 000101297520000250
Q3 2019 109 3,711,799 NBIX, GBT, MRTX, IOVA 13F-HR 11/14/2019 000101297519000707
Q2 2019 104 4,358,000 NBIX, GBT, MRTX, IOVA 13F-HR 8/14/2019 000101297519000583
Q1 2019 105 3,544,255 NBIX, FOLD, GBT, ZGNX RESTATEMENT 5/16/2019 000101297519000380
Q4 2018 101 2,627,578 NBIX, GBT, FOLD, ZGNX 13F-HR 2/14/2019 000101297519000177
Q3 2018 117 3,739,830 NBIX, FOLD, GBT, ZGNX 13F-HR 11/14/2018 000101297518001239
Q2 2018 125 3,814,393 NBIX, FOLD, GBT, ALNY RESTATEMENT 11/1/2018 000101297518001190
Q1 2018 137 3,570,243 NBIX, FOLD, GBT, ZGNX 13F-HR 5/15/2018 000101297518000425
Q4 2017 132 3,016,759 NBIX, FOLD, GBT, ALNY 13F-HR 2/14/2018 000101297518000171
Q3 2017 139 2,617,539 NBIX, FOLD, ALNY, GBT RESTATEMENT 11/14/2017 000101297517000846
Q2 2017 126 1,987,272 FOLD, NBIX, ALNY, GBT 13F-HR 8/14/2017 000101297517000624
Q1 2017 173 1,755,479 NBIX, GBT, FOLD, VSAR 13F-HR 5/15/2017 000101905617000467
Q4 2016 198 1,406,244 NBIX, TSRO, FOLD, SRPT RESTATEMENT 5/2/2017 000101905617000406
Q3 2016 196 1,549,231 SRPT, NBIX, FOLD, TSRO 13F-HR 11/14/2016 000101905616001648
Q2 2016 173 1,442,487 SRPT puts, NBIX, TSRO, FOLD 13F-HR 8/11/2016 000101905616001477
Q1 2016 170 1,140,104 FOLD, NBIX, SRPT, TSRO 13F-HR 5/16/2016 000101905616001336
Q4 2015 155 1,351,627 FOLD, NBIX, SRPT, DYAX 13F-HR 2/16/2016 000101905616001109
Q3 2015 158 1,252,059 FOLD, NBIX, SRPT, RTRX NEW HOLDINGS 11/17/2015 000101905615000911
Q3 2015 158 1,250,856 FOLD, NBIX, SRPT, RTRX 13F-HR 11/16/2015 000101905615000908
Q2 2015 173 1,660,639 FOLD, NBIX, RTRX, SRPT 13F-HR 8/14/2015 000101905615000685
Q1 2015 158 1,286,807 FOLD, NBIX, RTRX, TSRO 13F-HR 5/15/2015 000101905615000506
Q4 2014 150 1,192,435 FOLD, NBIX, ACRX, SRPT 13F-HR 2/17/2015 000101905615000222
Q3 2014 125 988,010 FOLD, NBIX, AFMD, SRPT RESTATEMENT 11/17/2014 000101905614001426
Q2 2014 117 1,019,307 SRPT, NBIX, ACRX, VRTX 13F-HR 8/14/2014 000101905614001053
Q1 2014 127 951,682 ACRX, NBIX, SRPT, VRTX 13F-HR 5/15/2014 000101905614000699
Q4 2013 110 832,601 CELG, ACRX, SRPT, VRTX 13F-HR 2/14/2014 000101905614000254
Additional filings from Perceptive Advisors LLC that have since been restated

13D and 13G Filings

All 13D and 13G filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.

Issuer % of Class Filed
Kardigan, Inc. 13D/A
KARD · 485925101
 8.8% 10/1/2026
Event 9/29/2026
Immatics N.V. 13D/A
IMTX · N44445109
 7.6% 8/27/2026
Event 8/26/2026
LeonaBio, Inc. 13D/A
LONA · 04746L203
 20.0% 8/25/2026
Event 8/22/2026
Solid Biosciences Inc. 13D/A
SLDB · 83422E204
 11.2% 8/14/2026
Event 6/30/2026
Nautilus Biotechnology, Inc. 13D/A
NAUT · 63909J108
 9.1% 8/14/2026
Event 6/30/2026
Trinity Biotech plc 13D/A
TRIB · 896438504
 9.9% 5/4/2026
Event 4/30/2026
MeiraGTx Holdings plc 13D/A
MGTX · G59665102
 12.6% 4/24/2026
Event 4/17/2026
Lyra Therapeutics, Inc. 13D/A
LYRA · 55234L105
 15.6% 8/14/2025
Event 8/12/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Astria Therapeutics, Inc. 13D/A
ATXS · 04635X102
 0% 2/9/2026
Event 1/26/2026
Lyra Therapeutics, Inc. 13D/A
LYRA · 55234L204
 0% 11/25/2025
Event 11/21/2025

63 other securities where the latest filing is a 13G, the newest filed 9/23/2026. View all